Tetravalent influenza vaccine（MDCK cell） (Shanghai Institute Of Biological Products)

四价流感病毒裂解疫苗（MDCK细胞）（上海生物制品研究所）

Report date: 2024/04/07 17:05:22

Base Information

Drug NameTetravalent influenza vaccine（MDCK cell） (Shanghai Institute Of Biological Products)

Drug Alias Name基于无血清全悬浮细胞培养的流感疫苗（上海生物制品研究所）Quadrivalent Influenza Virus Split Vaccine（MDCK cell） (Shanghai Institute Of Biological Products)

ClassificationVaccines > Biological material > Viral vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesShanghai Institute of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A